COHANCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Cohance Lifesciences Limited (formerly Suven Pharmaceuticals Limited) has notified stock exchanges that the audio recording of its Q4 and FY 2026 earnings conference call held on May 12, 2026 is now available on the company's website. The call covered the quarter and year ended March 31, 2026. This filing is a standard regulatory compliance notification — it does not contain the actual discussion content or any material details from the call itself. Investors seeking insights from management would need to access the audio file directly at the provided link.
The filing itself contains no new financial or strategic information. It merely provides access to an earnings call recording where any material disclosures would have been made verbally.